Polypharmacy Thresholds that Best Predict Emergency Room Visits and Mortality in Older Adults: A Population-Based Study in Québec, Canada
Open Access
- 28 October 2025
- journal article
- Published by SAGE Publications in Journal of Applied Gerontology
- Vol. 45 (9) , 1809-1821
Abstract
Background: Polypharmacy is prevalent among older adults. Identifying informative medication thresholds could enhance clinical decision-making and healthcare planning. Objectives: To measure the predictive capacity of medication count and polypharmacy thresholds on (1) frequent emergency visits and (2) mortality, in community-dwelling older adults in Quebec, Canada; To measure the predictive capacity of inappropriateness criteria (potentially inappropriate medications, anticholinergic burden level, and drug–drug interactions) on these same outcomes. Methods: We conducted a population-based study using the Quebec Integrated Chronic Disease Surveillance System. Using multivariable logistic regression models, we assessed the predictive capacity [area under the curve (AUC)] of medication use (medication count, polypharmacy thresholds, number of inappropriateness criteria) on frequent emergency visits (≥3) and mortality from April 2, 2022, to March 31, 2023. Findings were interpreted from two perspectives: clinical (with models including individuals’ clinical characteristics, such as chronic diseases) and public health (with models excluding clinical characteristics to mimic polypharmacy measures usually used in surveillance). Results: Medication count remained the most informative predictor in the clinical perspective analyses, with AUC = 0.739 for frequent emergency visits and AUC = 0.804 for one-year mortality, while medication thresholds lacked discrimination. Public health perspective analyses resulted in a bell-shaped predictive pattern peaking at eight medications for both frequent emergency visits (AUC = 0.690) and one-year mortality (AUC = 0.764). Inappropriateness criteria did not outperform medication count or polypharmacy thresholds. Conclusion: From a clinical perspective, medication count is more informative than polypharmacy thresholds. From a public health perspective, a threshold of eight medications may serve as a useful polypharmacy measure.Keywords
Funding Information
- Canadian Institute of Health Research and the Natural Sciences and Engineering Research Council of Canada (CPG—170621)
- Santé (Junior 2 salary grant)
This publication has 27 references indexed in Scilit:
- Assessing the feasibility of anticholinergic burden scales and measures in administrative data: A systematic reviewArchives of Gerontology and Geriatrics, 2024
- Machine learning-based prediction model for emergency department visits using prescription information in community-dwelling non-cancer older adultsScientific Reports, 2023
- Classifying Polypharmacy According to Pharmacotherapeutic and Clinical Risks in Older Adults: A Latent Class Analysis in Quebec, CanadaDrugs & Aging, 2023
- Association of polypharmacy with all‐cause mortality and adverse events among elderly colorectal cancer survivorsCancer, 2023
- Association between polypharmacy and death: A systematic review and meta-analysisJournal of the American Pharmacists Association, 2017
- Polypharmacy cut-points in older people with cancer: how many medications are too many?Supportive Care in Cancer, 2015
- A systematic review identifies valid comorbidity indices derived from administrative health dataJournal of Clinical Epidemiology, 2015
- Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomesJournal of Clinical Epidemiology, 2012
- Frequent Users of Emergency Departments: The Myths, the Data, and the Policy ImplicationsAnnals of Emergency Medicine, 2010
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007